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ABSTRACT 
Objective 
We assessed the association between population resection rates, hospital procedure volume and death rates 
in pancreatic cancer patients in England.  
Design 
Patients diagnosed with pancreatic cancer were identified from a linked cancer registration and Hospital 
Episode Statistics dataset.  Cox regression analyses were used to assess all-cause mortality according to 
resection quintile and hospital volume, adjusting for sex, age, deprivation and comorbidity.   
Results  
There were 31,973 pancreatic cancer patients studied, 2,580 had surgery.  Increasing resection rates were 
associated with lower mortality among all patients (χ
2
(1df)=176.18, ptrend<0.001), with an unadjusted hazard 
ratio (HR) of 0.78 95%CI[0.75 to 0.81] in the highest versus the lowest resection quintile.  Adjustment changed 
the estimate slightly (HR 0.82, 95%CI[0.79 to 0.85], (χ
2
(1df)=99.44, ptrend<0.001)).  Among patients that 
underwent surgery, higher procedure volume was associated with lower mortality (HR=0.88 95%CI[0.75-1.03] 
in hospitals carrying out 30+ versus <15 operations a year, shared frailty model, χ
2
(1df)=1.82, ptrend=0.177). 
Conclusion 
Higher population resection rates were associated with lower mortality.  The association with hospital 
procedure volume was less clear possibly due to small number of patients who underwent surgery.  
Nevertheless these results suggest survival is higher in hospitals that carry out a greater number of operations 
a year, particularly those doing 30+ operations, supporting the benefit of centralising perioperative expertise 
in specialist centres.  Ensuring people are increasingly diagnosed when they are suitable candidates for 
surgery, and have access to these specialist centres may lead to an increase in the proportion of patients that 
undergo surgical resection which could plausibly increase survival of pancreatic cancer patients. 
 
 
Key words: Population resection rate, hospital procedure volume, survival, pancreatic cancer, England 
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INTRODUCTION 
In 2010, around 7,000 persons were diagnosed with pancreatic cancer in England.[1]  Pancreatic cancer 
survival is poor with 3.7% of patients surviving five or more years after diagnosis.[2]  Surgical resection offers 
the chance of a cure for patients with early stage tumours, but pancreatic cancer is often diagnosed at an 
advanced stage of disease and curative surgery is only possible for a minority of patients.[3, 4]   
 
Pancreatic resection is a complex surgical procedure with a high risk of postoperative mortality and morbidity.  
A study in the US by Birkmeyer et al of Medicare patients treated between 1994 and 1999 found that across all 
14 procedures studied (8 of which were for cancer) mortality was lower in higher volume hospitals, with 
absolute differences in mortality between very-low and very-high volume groups most pronounced for 
pancreatic resections.[5]  In general, studies have found an association between higher hospital procedure 
volume, lower post-operative mortality and long-term survival following surgery for pancreatic cancer, 
although not all these studies reported a statistically significant association.[5-10]  In 2001, the Upper 
Gastrointestinal Cancer Improving Outcomes Guidance proposed that surgical referrals for pancreatic cancer 
should be centralised to specialist centres.[11]  Within this framework, the Association of Upper 
Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) recommend that hospitals should draw from a 
population of 2-4 million which should result in at least 80-100 pancreatic resections being carried out per 
year, of which some would be carried out for related peri-ampullary tumours and other conditions such as 
chronic pancreatitis.[12]  In most centres, pancreatic cancer accounts for less than half of all pancreatic 
resections.[13] 
 
Previous studies from our group that focused on oesophageal and gastric cancer [14] and on lung cancer [15] 
found lower death rates in areas where a higher proportion of patients underwent surgical resection.  We also 
found lower death rates in patients operated in hospitals that carry out a greater number of operations a year 
despite an adverse case-mix in the higher procedure volume hospitals.[14, 16]  No study has investigated the 
association between population-based resection rates and mortality or the impact of hospital procedure 
volume on survival in pancreatic cancer patients in England following the 2001 Improving Outcomes Guidance.  
The present study aimed to assess the associations between population resection rate, hospital procedure 
volume and survival for patients with pancreatic cancer in England, taking into account differences in case-mix 
including age, sex, socioeconomic deprivation and comorbidity. 
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METHODS 
Data on 34,135 pancreatic (ICD10 C25) cancers diagnosed in England between 2005 and 2009 were extracted 
from the National Cancer Data Repository, which contains information collected by the former regional cancer 
registries in England.  Death information was obtained from the National Health Service central register via the 
Office for National Statistics.  Registrations which only had information from a death certificate (n=2,099) and 
had no NHS number (n=61) were excluded.  For patients registered with more than one primary pancreatic 
cancer tumour the earlier tumour was selected which excluded a further two records, leaving 31,973 patients 
in the final dataset.  
Patient characteristics 
Age at diagnosis was aggregated into five-year groups.  Patients were grouped into quintiles of socioeconomic 
deprivation based on their postcode and lower super output area (each comprising a population of around 
1,500 people) of residence.  The income domain of the 2007 Indices of Deprivation [17] was used for patients 
diagnosed between 2005 and 2006, and the income domain of the 2010 Indices of Deprivation [18] was used 
for patients diagnosed between 2007 and 2009.  Comorbidity information was obtained from a linked Hospital 
Episode Statistics (HES) admitted patient dataset supplied by the Health and Social Care Information Centre.  
For each patient, a comorbidity score was derived using non-cancer diagnosis codes recorded within inpatient 
and day case episodes between two years prior to and three months after the patient’s date of cancer 
diagnosis.[19]  Standard weights were assigned according to the severity of the condition,[20] and the 
resulting scores were aggregated into four categories of increasing severity of comorbidity: 0 (no comorbidity) 
through to 3+ (score of 3 or higher).   
Pancreas surgery information, defined as pancreatectomy, pancreaticoduodenectomy and other total or 
subtotal excisions of the pancreas (OPCS4 J55.1-J55.2, J55.8-J55.9, J56.1-J56.9, J57.1-J57.5, J57.8-J57.9), was 
obtained from the HES dataset.  The first surgical procedure for each patient from one month before to six 
months after the diagnosis date was extracted.  
Population resection quintile and hospital procedure volume 
The resection rate was defined as the proportion of pancreatic cancer patients in each primary care trust 
geographical area that underwent surgical resection in each year of diagnosis.  These proportions were then 
grouped into population resection quintiles representing areas with increasing proportions of resected 
patients.   
The number of operations was available at the organisation level of NHS hospital trust.  In England, an NHS 
hospital trust manages one or more local hospitals.  In this paper, we refer to NHS hospital trusts simply as 
"hospitals", and the annual number of operations in a trust is referred to as the "hospital procedure volume".  
For each pancreatic cancer patient that underwent surgical resection, hospital procedure volume was 
computed as the number of pancreatic cancer operations carried out in the hospital in which they were 
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treated and in the same year as their diagnosis.  Three groups were defined based on quantiled distributions 
with the boundaries readjusted slightly to form sensible groupings: <15 operations per year, 15-29, and 30+ 
operations per year.  There were 91 individual hospitals included in the analysis, of which 62 individual 
hospitals contributed to the <15 volume group and nine individual hospitals to the 30+ group in at least one 
diagnosis year. 
Data analysis 
The numbers and proportions of patients who underwent surgical resection by population resection quintile, 
hospital procedure volume and case-mix variables, i.e. sex, age, socioeconomic deprivation and comorbidity, 
were tabulated.  P-values for trend or heterogeneity were calculated, as appropriate.  Univariate and 
multivariate Cox proportional hazards regression analyses were used to estimate the all-cause mortality 
hazard ratios (HRs) and 95% confidence intervals (CIs) according to population resection quintile, hospital 
procedure volume and the case-mix variables.  Analyses of hospital procedure volume were performed on the 
subset of patients who underwent surgical resection (n=2,580). 
For all patients, survival time was calculated from the diagnosis date until death from any cause or censored at 
end of study on 31
st
 December 2010.  In the analysis restricted to patients who underwent surgical resection, 
survival time was calculated from the operation date.  Adjustment was made for identified potential 
confounders including sex, age, socioeconomic deprivation, comorbidity and population resection quintile.  To 
account for any potential variation in the risk of death between groups of patients treated in particular 
hospitals, a shared frailty Cox model was used, with hospital as a random effect.   
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RESULTS 
Of 31,973 patients diagnosed with pancreatic cancer in England between 2005 and 2009 included in this study, 
2,580 (8.1%) underwent surgical resection (Table 1).  The annual proportion of patients that had surgery in 
each of the 151 primary care trusts of residence ranged from 0% to 29% and the annual number of patients 
undergoing surgery in each hospital ranged from 1 to 55.   
The proportion of patients that had surgery decreased with age (from 17.9% in patients aged 55 or less to 0.2% 
for patients aged 85+), socioeconomic deprivation (from 9.1% to 7.2% in the least to most deprived quintile), 
and severity of comorbidity (from 10.1% for patients with no recorded comorbidity to 5.2% for patients with a 
comorbidity score of 3 or more), (all with ptrend<0.001).  Women were less likely to undergo surgery than men 
(7.6% vs. 8.6%, p=0.002).  Patients that underwent surgery in high volume hospitals were more likely to live in 
areas where a higher proportion of patients underwent surgical resection (χ
2
(1df)=132.65, p<0.001) and were 
more likely to have more severe comorbidity (χ
2
(1df)=4.58, p=0. 032). 
Among all patients, increasing resection rates were associated with lower death rates (χ
2
(1df)=176.18, 
ptrend=<0.001), with a HR of 0.78 (95%CI 0.75 to 0.81) in the highest compared with the lowest population 
resection quintile (Table 2).  Adjustment for age and sex (HR=0.82, 95%CI 0.79 to 0.85, χ
2
(1df)=105.03, 
ptrend<0.001), and further adjustment for socioeconomic deprivation and comorbidity attenuated the 
association a little (HR=0.82, 95%CI 0.79 to 0.85, χ
2
(1df)=99.44, ptrend<0.001).  Without any adjustment, one-
year survival ranged from 12.8% to 21.4% in the lowest to the highest resection quintile.  Five-year survival 
ranged from 2.0% to 4.4% respectively. 
Over the five-year period studied, there was an increase in the proportion of patients who underwent surgical 
resection in hospitals carrying out 30+ operations a year (20% in 2005 to 57% in 2009), and a corresponding 
decrease from 50% to 15% in hospitals carrying out <15 operations a year (Figure 1).   
Regarding hospital procedure volume, the unadjusted HR for the highest (30+ operations per year) compared 
with the lowest volume group (<15 operations a year) was 0.96, 95%CI 0.85 to 1.08, χ
2
(1df)=0.52, ptrend=0.472 
(Table 3).  Adjustment for age and sex made little material difference (0.94 (95%CI 0.84 to 1.06, χ
2
(1df)=0.92, 
ptrend=0.338).  The shared frailty model strengthened the HR to 0.88 (95%CI 0.75 to 1.03, χ
2
(1df)=1.82, 
ptrend=0.177) suggesting a marginal survival benefit in the largest procedure volume group but not reaching 
statistical significance.  The hazard ratios in the short term (<30 days after surgery) were lower (HR 0.69 [0.37 
to 1.32]) than those in the longer term; 31-365 days (HR 0.93 [0.74 to 1.17]) and >365 days (HR 0.91 [0.75 to 
1.11]), after adjusting for case mix and resection quintile. 
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DISCUSSION 
This study found variation in the proportion of pancreatic cancer patients that underwent surgical resection in 
England in the five-year period between 2005 and 2009.  In absolute terms, the difference in the unadjusted 
survival between the lowest and the highest resection quintile was greater at one-year compared with five-
years after diagnosis.  After adjustment for age, sex, socioeconomic deprivation and comorbidity, areas with 
higher resection rates had higher survival.  This is consistent with our previous studies for oesophageal and 
gastric cancer [14] and for lung cancer.[15]  The association between hospital procedure volume and survival 
was in the direction of higher survival in larger volume hospitals, but the association was not statistically 
significant. 
Whether or not a patient undergoes surgical resection depends on several factors.  Adjustment for case-mix 
variables, which frequently affect long-term survival such as age, sex, socioeconomic deprivation and 
comorbidity made little material difference to the findings which could suggest, at the very least these, 
patient-level factors were not the main reason for the lower death rates in the higher resection rate areas.  
Therefore, we propose that factors related to service provision, such as the availability of specialist surgical 
teams and appropriate supportive care, the presence of effective multidisciplinary team decision making and 
the tendency and/or ability to operate on higher-risk patients in some areas, may be relatively more 
important.  If these findings are the result of non-patient related factors, increasing the proportion of patients 
who undergo surgical resection could plausibly lead to an increase in survival for patients with pancreatic 
cancer.  Quality of life will also be an important consideration when deciding whether it is appropriate to offer 
surgery to a greater number of patients.  Therefore, it is important to ensure all pancreatic cancer patients 
who could potentially benefit from specialist expertise are referred to dedicated multidisciplinary teams.   
Our previous studies on the association between hospital procedure volume and death rates in England for 
oesophageal and gastric cancer [14] and for lung cancer [16] found there was lower mortality in hospitals that 
carried out a greater number of operations per year.  Other studies have found an association between higher 
hospital volume and lower post-operative mortality following surgery for pancreatic cancer.[5-9, 21]  In the 
present study the association between hospital procedure volume and survival was strengthened by 
adjustment for case-mix and resection quintile but it did not reach statistical significance.  It is feasible that this 
study was underpowered since only nine hospitals carried out 30 or more procedures per year in at least one 
year during the period.  It is recognised that this study does not completely reflect the volume of pancreatic 
resections carried out in these hospitals as the volume measure was only based on pancreatic cancer patients, 
however, it suggests a survival benefit for patients operated on in hospitals undertaking 30 or more pancreatic 
cancer operations a year.   
The principal strength of this study was that it used a population-based cancer registration and Hospital 
Episode Statistics linked dataset which included all patients diagnosed with pancreatic cancer in a five-year 
period in the whole of England.  It also covered a period when centralisation of surgical services in England was 
on-going with a clear increase in the proportion of pancreatic cancer patients who underwent surgical 
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resection in hospitals carrying out 30+ operations a year.  Surgical information was obtained from the HES 
admitted patient dataset and was more complete than surgery information recorded in the cancer registration 
process.  A systematic review found acceptable accuracy for procedure codes from NHS administrative 
data.[22] 
Information on tumour stage, performance status and location of the tumour was not available in our dataset.  
These factors are associated with survival and define a patient’s suitability to undergo surgery.  It could be 
argued that the lower mortality in higher volume hospitals is associated with the selective referral of patients 
who have less advanced stage and have better fitness for surgery.  However, it is evident that patients 
undergoing surgery in higher volume hospitals included a greater proportion of patients with comorbidity and 
adverse case-mix.  Adjustment for the available case-mix factors strengthened the association between 
volume and mortality.  Therefore, the absence of adjustment for other factors like stage may imply that the 
analysis actually underestimates the true difference between hospital volume groups.  It was also not possible 
to take into account other non-surgical treatments such as chemotherapy and radiotherapy.  Patients in the 
higher volume groups may be more likely to get other non-surgical treatments in combination with their 
surgery which could lead to better outcomes.  Therefore, taking these other treatments into account could 
explain part of this association between hospital volume and survival.  As the association between population 
resection quintiles and death rates was not affected by adjustment for other case-mix factors including 
comorbidity it suggests, as discussed earlier, that non-patient factors are more likely to explain the variation in 
resection rates.  Therefore it is considered unlikely that the inclusion of stage information would materially 
change the resection rate findings.   
Higher population resection rates were associated with lower mortality in pancreatic cancer patients.  Due to 
the absence of information on stage and non-surgical treatment, future studies to assess the relationship 
between resection rate, stage, survival and quality of life in more detail should be carried out in order to 
ascertain whether there is genuine scope to offer surgical resection to a greater number of patients.  The 
association between hospital procedure volume and survival was in the direction of higher survival in larger 
volume hospitals particularly those doing 30 or more operations a year, but it did not reach statistical 
significance.  This study supports the benefit of centralising expertise including surgery and perioperative care 
in specialist centres. 
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Table 1: Characteristics of patients diagnosed with pancreatic cancer (ICD10 C25) in England between 2005 
and 2009 
        Hospital procedure volume   
  Total 
number 
of 
patients 
Total 
number 
resected 
% 
resected 
χ
2
 (1) df
3
,          
p-value 
<15 
 
% 
15-29 
 
% 
30+ 
 
% 
Mantel-
Haenszel  
χ
2 
(1) df
c
, 
p-value 
           31,973       2,580               8.1  n =    802  n =    854  n =    924    
Hospital procedure volume
a
 
<15            802            31.1                
15-29            854            33.1          
30+            924            35.8          
No surgery     29,393             
Resection quintile
b
 
Quintile 1 (0.0-4.5)       6,411          145               2.3       8.4       4.7       4.1    
Quintile 2 (4.5-6.3)       6,549           356               5.4    20.8    13.2      8.2    
Quintile 3 (6.3-8.5)      6,276           468               7.5    23.6    15.8    15.6    
Quintile 4 (8.5-11.3)       6,360           621               9.8    19.6    32.1    20.6    
Quintile 5 (11.4-29.2)       6,377           990            15.5    27.7    34.2    51.5    
     763.02       132.65      
     <0.001       <0.001 
Sex 
Male     15,691       1,342               8.6     49.3     53.5     53.0    
Female     16,282       1,238               7.6    50.7    46.5    47.0    
     9.69       2.32      
     0.002       0.128    
Age group 
<55       2,547           457            17.9    17.2    19.2    16.8    
55-59       2,366           315            13.3    12.2    11.8    12.6    
60-64       3,429           434            12.7    16.6    18.1    15.8    
65-69       4,198           495            11.8    19.2    19.2    19.2    
70-74       4,915           439               8.9    18.5    14.6    18.0    
75-79       5,317           366               6.9    13.8    14.4    14.3    
80-84       4,654             66               1.4      2.2      2.3      3.0    
85+       4,547               8               0.2      0.2      0.2      0.4    
     1095.76       0.43      
     <0.001       0.510    
Socioeconomic deprivation 
1 = Most affluent       6,137          560               9.1    20.7    20.4    23.8    
2       6,978          600               8.6    26.9    21.3    21.9    
3       6,935           556               8.0    21.8    22.0    20.9    
4       6,430           466               7.2    18.3    17.9    18.0    
5 = Most deprived       5,493           398               7.2    12.2    18.4    15.5    
     21.60       0.42      
     <0.001       0.518    
Comorbidity score 
0     15,027       1,514            10.1    61.1    59.8    55.5    
1       8,302          737               8.9    26.7    27.9    30.8    
2       3,080           209               6.8      8.2      7.8      8.2    
3+       2,316           120               5.2      4.0      4.4      5.4    
Not known       3,248               -                    -           -           -            -      
     78.99       4.58      
      <0.001             0.032    
a 
The proportion resected for hospital procedure volume is calculated out of those who underwent surgery  
b 
Proportion of pancreatic cancer patients in each primary care trust area that underwent surgical resection
  
c
 For comorbidity, those with a not known comorbidity score were excluded
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Table 2: Hazard ratios (HR) and 95% confidence intervals (95%CI) according to population resection quintile 
for all patients diagnosed with pancreatic cancer between 2005 and 2009 
Resection Quintile 
Unadjusted Adjusted for age and 
sex 
Adjusted for age, 
sex, socioeconomic 
deprivation and 
comorbidity 
Quintile 1 (0.0-4.5) 1.00   1.00   1.00   
Quintile 2 (4.5-6.3) 0.90 (0.87-0.93) 0.90 (0.87-0.93) 0.91 (0.88-0.95) 
Quintile 3 (6.3-8.5) 0.90 (0.87-0.94) 0.93 (0.89-0.96) 0.94 (0.91-0.97) 
Quintile 4 (8.5-11.3) 0.86 (0.83-0.90) 0.89 (0.86-0.92) 0.90 (0.87-0.93) 
Quintile 5 (11.4-29.2) 0.78 (0.75-0.81) 0.82 (0.79-0.85) 0.82 (0.79-0.85) 
χ
2 
(1) 176.18   105.03   99.44   
p for trend <0.001   <0.001   <0.001   
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Figure 1: Proportion of patients undergoing surgical resection in each hospital procedure volume group, <15 
operations a year, 15-29 operations a year, and 30 or more operations a year. 
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Table 3: Hazard ratios (HR) and 95% confidence intervals (95%CI) according to hospital procedure volume 
among resected patients diagnosed with pancreatic cancer 
Hospital 
procedure 
volume 
Unadjusted Adjusted for age and 
sex 
Shared frailty model 
adjusted for age, sex, 
socioeconomic 
deprivation, co-
morbidity score, 
resection quintile and 
hospital (random 
effect) 
<15 1.00   1.00   1.00   
15-29 1.07 (0.96-1.21) 1.09 (0.97-1.23) 1.02 (0.89-1.16) 
30+ 0.96 (0.85-1.08) 0.94 (0.84-1.06) 0.88 (0.75-1.03) 
χ2 (1) 0.52   0.92   1.82   
p for trend 0.4722   0.3377   0.1774   
 
 
 
